NCT04295655

Physiotherapy in Hypoxic AECOPD Patients

Status unknown NA Last updated 4 March 2020

What this trial tests

NA trial testing Global Exercise intervention in COPD Exacerbation in 36 participants. Status unknown.

Timeline

1 December 2019

Primary endpoint
1 January 2020

1 April 2020

Quick facts

Lead sponsor	Universidad de Granada
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	36
Start date	1 December 2019
Primary completion	1 January 2020
Estimated completion	1 April 2020
Sites	1 location across Spain

Drugs / interventions tested

• Global Exercise intervention
• Functional Electrostimulation Group
• Standard treatment

Conditions studied

• COPD Exacerbation — all drugs for COPD Exacerbation →

Sponsor

Universidad de Granada — full company profile →

Who can join

40 and older, any sex, with COPD Exacerbation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hypoxia is considered a key player in many of the comorbidities that characterize COPD, such as pulmonary hypertension, skeletal muscle dysfunction, and systemic inflammation. These comorbidities are worsened during an exacerbation due to prolonged bed rest and treatment with steroids, showing a reduction in the quality of life, exercise tolerance, and a greater risk of death in these patients. Therefore, a better understanding of the safety and effectiveness of exercise training for AECOPD patients with resting hypoxemia is needed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. A Feasibility and Efficacy Randomized Controlled Trial of Two Exercise Programs in Severe AECOPD Patients with Resting Hypoxemia.
   López-López L, Calvache-Mateo A, Rodríguez-Torres J, Granados-Santiago M, et al · · 2021 · cited 5× · PMID 34574876 · DOI 10.3390/healthcare9091102